Cointime

PathDrugomics

company

About

Increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market.

  • 1 - 10

Highlights

Total Funding Amount
$28K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
$28K
Industries
Artificial Intelligence,Biotechnology,Clinical Trials,Health Diagnostics,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

PathDrugomics exponentially increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market. Our products utilize the speed of accelerating computational technologies and the intelligence of big data analytics to model interactions between newly discovered drugs and their possible targets within diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$28K
PathDrugomics has raised a total of $28K in funding over 2 rounds. Their latest funding was raised on Jul 10, 2013 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 10, 2013 Seed $28K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
PathDrugomics is funded by 1 investors. Alchemist Accelerator are the most recent investors.
Investor Name Lead Investor Funding Round
Alchemist Accelerator — Seed
Cointime
เนื้อหา
บริษัท